Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib

M Massa, V Rosti, R Campanelli, G Fois, G Barosi - Leukemia, 2014 - nature.com
M Massa, V Rosti, R Campanelli, G Fois, G Barosi
Leukemia, 2014nature.com
3 Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term
follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102:
3759–3764. 4 Waldenstrom J. Incipient myelomatosis or ''essential''hyperglobulinemia with
fibrinogenopenia—a new syndrome? Acta Med Scand 1944; 117: 216–247. 5 Kristinsson
SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of
lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma …
3 Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102: 3759–3764. 4 Waldenstrom J. Incipient myelomatosis or ‘‘essential’’hyperglobulinemia with fibrinogenopenia—a new syndrome? Acta Med Scand 1944; 117: 216–247. 5 Kristinsson SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population based study in Sweden. Blood 2008; 112: 3052–3056. 6 Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al. MYD88 L265P somatic mutation in Waldenstrom’s macroglobulinemia. N Engl J Med 2012; 367: 826–833. 7 Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X et al. MYD88 L265P in Waldenströ m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013; 121: 2051–2058. 8 Landgren O, Staudt L. MYD88 L265P somatic mutation in IgM MGUS [letter].
nature.com